On the Australian Securities Exchange, the ticker symbol PCK stands for PainChek Limited, an innovative healthcare technology company. The enterprise is globally recognized for developing a clinically validated, smartphone-based artificial intelligence application designed to assess and score pain levels in individuals who are unable to communicate effectively, such as patients suffering from advanced dementia, cognitive impairments, or young children in clinical settings.